Hospital de Cruces
In research, Hospital de Cruces stands highest in Medicine (#3,964 of 10,443 worldwide) and Health Sciences (#5,324 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 6.0× its share of world research.
- World rank, 2022–2025
- #11,604 of 28,054 · #11,367 all time
- Rank in Spain
- #304 of 658
- Research works
- 3.5k ▲ 13% vs 2013–17
- Citations
- 46k 13.2 per fractional work
- Top-10% rate
- 7.4% record average 16.5%
- Open access
- 29% world 28%
What is Hospital de Cruces known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,964 of 10,443 | 6.9% | 336 | #2966 | |
| Health SciencesDomain | #5,324 of 11,982 | 7.0% | 355 | #3716 |
Each strip is that field’s whole ranked pool, with the notch where Hospital de Cruces sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Hospital de Cruces specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 6.0× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 39.8 works6.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.
- Medicine 4.1×
- Immunology and Microbiology 2.9×
- Veterinary 2.2×
- Nursing 1.3×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Health Professions 1.2×
- Neuroscience 0.9×
- Dentistry 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Psychology 0.4×
- Economics, Econometrics and Finance 0.2×
- Chemistry 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Materials Science 0.1×
- Decision Sciences 0.1×
- Environmental Science 0.1×
- Mathematics 0.1×
- Physics and Astronomy 0.1×
- Social Sciences 0.1×
- Computer Science 0.0×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
- Chemical Engineering 0.0×
Who are the top researchers at Hospital de Cruces?
Ranked on the composite score, Fernando Pérez-Ruiz, Itziar Astigarraga and J.L. Díaz-Pérez lead among researchers whose main affiliation is Hospital de Cruces.
- 1 Fernando Pérez-Ruiz Spain · #10,638 worldwide 1.7k citations · 47 works
- 2 Itziar Astigarraga Spain · #226,551 worldwide 113 citations · 33 works
- 3 J.L. Díaz-Pérez Spain · #240,017 worldwide 86 citations · 24 works
- 4 Sonia Gaztambide Spain · #241,225 worldwide 125 citations · 26 works
- 5 Luís Castaño Spain · #266,931 worldwide 130 citations · 38 works
- 6 Alfredo Vallo Spain · #314,422 worldwide 94 citations · 23 works
- 7 Juan Rodríguez‐Soriano Spain · #349,564 worldwide 67 citations · 21 works
- 8 Olga Merino Spain · #350,641 worldwide 79 citations · 19 works
- 9 Guillermo López-Vivanco Spain · #504,186 worldwide 63 citations · 41 works
- 10 Mikel Prieto Spain · #515,137 worldwide 52 citations · 25 works
Which keywords describe research at Hospital de Cruces?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Treatment, Immunotherapy, Prognostic Factors, Chemotherapy, Management and Genetic Mutations.
- Temozolomide
- Neurodevelopmental Outcomes
- Rituximab
- Nutritional Support
- Prognosis
- Endothelial Dysfunction
- Thrombosis
- Tumor Microenvironment
- Clinical Management
- Echocardiography
- Mortality
- Metabolic Syndrome
- Cardiovascular Disease
- Radiotherapy
- Risk Factors
- Genetic Mutations
- Management
- Chemotherapy
- Immunotherapy
- Diagnosis
- Epidemiology
- Treatment
- Inflammation
- Prognostic Factors
- Clinical Practice Guidelines
- Quality of Life
- Surgical Management
- Pathogenesis
- Complications
- Surgery
- Guidelines
- Molecular Classification
- Treatment Guidelines
- Neoadjuvant Therapy
- Pancreatic Cancer
- Antimicrobial Resistance
- Hypertension
- Prophylaxis
- Percutaneous Coronary Intervention
- Glioblastoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology70▲ 4.2×115 topics
- Diagnosis27▲ 6.8×38 topics
- Treatment26▲ 5.0×41 topics
- Immunotherapy21▲ 6.9×17 topics
- Inflammation20▲ 2.3×61 topics
- Chemotherapy18▲ 6.1×24 topics
- Prognostic Factors18▲ 9.6×14 topics
- Management16▲ 4.9×25 topics
- Clinical Practice Guidelines14▲ 5.8×14 topics
- Genetic Mutations13▲ 7.2×21 topics
- Quality of Life13▲ 2.0×32 topics
- Risk Factors13▲ 2.7×23 topics
- Surgical Management13▲ 7.2×19 topics
- Radiotherapy12▲ 7.2×12 topics
- Pathogenesis11▲ 5.2×22 topics
- Cardiovascular Disease10▲ 2.1×30 topics
- Complications10▲ 4.7×16 topics
- Metabolic Syndrome9▲ 2.7×19 topics
- Surgery9▲ 5.8×11 topics
- Mortality8▲ 3.4×11 topics
- Guidelines8▲ 4.0×12 topics
- Echocardiography8▲ 6.8×8 topics
- Molecular Classification8▲ 12×4 topics
- Clinical Management8▲ 10×8 topics
- Treatment Guidelines7▲ 8.0×6 topics
- Tumor Microenvironment7▲ 3.9×7 topics
- Neoadjuvant Therapy7▲ 7.3×5 topics
- Thrombosis7▲ 6.1×7 topics
- Pancreatic Cancer7▲ 15×3 topics
- Endothelial Dysfunction7▲ 7.1×5 topics
- Antimicrobial Resistance6▲ 7.6×9 topics
- Prognosis6▲ 4.7×9 topics
- Hypertension6▲ 5.1×8 topics
- Nutritional Support6▲ 15×3 topics
- Prophylaxis6▲ 11×4 topics
- Rituximab6▲ 8.8×4 topics
- Percutaneous Coronary Intervention6▲ 9.5×4 topics
- Neurodevelopmental Outcomes5▲ 6.7×6 topics
- Glioblastoma5▲ 18×1 topic
- Temozolomide5▲ 18×1 topic
Which research topics does Hospital de Cruces publish most on?
By volume in 2022–2025: Glioma Diagnosis and Treatment, Cardiac Valve Diseases and Treatments, Pancreatic and Hepatic Oncology Research and Pancreatitis Pathology and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Glioma Diagnosis and Treatment Genetics 5 works
- 2 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 5 works
- 3 Pancreatic and Hepatic Oncology Research Oncology 5 works
- 4 Pancreatitis Pathology and Treatment Surgery 4 works
- 5 Poisoning and overdose treatments Emergency Medicine 4 works
- 6 Infective Endocarditis Diagnosis and Management Epidemiology 3 works
- 7 Congenital Heart Disease Studies Epidemiology 3 works
- 8 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 9 Obstructive Sleep Apnea Research Physiology 3 works
- 10 Esophageal and GI Pathology Surgery 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hospital de Cruces's research output changed?
Output in 2018–2022 was 13% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Barakaldo
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.